{"mainPropery":{"diseaseId":8249,"diseaseName":"Sideroblastic anemia pyridoxine-refractory autosomal recessive","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8249/sideroblastic-anemia-pyridoxine-refractory-autosomal-recessive","synonyms":["Pyridoxine refractory sideroblastic anemia","Refractory anemia with ringed sideroblasts","RARS","AISA","Primary acquired sideroblastic anemia","Acquired idiopathic sideroblastic anemia"],"synonyms-with-source":[{"name":"Pyridoxine refractory sideroblastic anemia"},{"name":"Refractory anemia with ringed sideroblasts"},{"name":"RARS"},{"name":"AISA","source":"OrphaData.Org"},{"name":"Primary acquired sideroblastic anemia","source":"OrphaData.Org"},{"name":"Acquired idiopathic sideroblastic anemia","source":"Orphanet"}],"identifiers":[{"identifierType":"OMIM","identifierId":"205950"},{"identifierType":"ORPHANET","identifierId":"75564"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":167,"resourceName":"Iron Disorders Institute Inc.","abbreviation":"","address1":"P.O. Box 4891","address2":"","address3":"","address4":"","address5":"","city":"Greenville","state":"SC","zip":"29608","country":"United States","phone":"","tty":"","tollFree":"","fax":"864-292-1878","email":"info@irondisorders.org","url":"http://www.irondisorders.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/205950' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=205950' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Sideroblastic anemia pyridoxine-refractory autosomal recessive. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Sideroblastic+anemia+pyridoxine-refractory+autosomal+recessive%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Sideroblastic anemia pyridoxine-refractory autosomal recessive. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1389794-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=75564' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/professional/hematology_and_oncology/anemias_caused_by_deficient_erythropoiesis/sideroblastic_anemias.html?qt=&sc=&alt=' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:205950' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":5555,"questionText":"What is sideroblastic anemia pyridoxine-refractory autosomal recessive?","answerText":"<strong>Sideroblastic anemia pyridoxine-refractory autosomal recessive </strong>is an inherited blood disorder that is&nbsp;characterized by an impaired ability of the bone marrow to produce normal red blood cells. The iron inside red blood cells is inadequately used to make <a href=\"http://sickle.bwh.harvard.edu/hemoglobin.html\" target=_blank>hemoglobin</a>, despite adequate or increased amounts of iron. Abnormal red blood cells called sideroblasts are found in the blood of people with this&nbsp;anemia.[1837] It is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene/SLC25A38\" target=_blank><em>SLC25A38</em></a> gene. It is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> fashion. Unlike other forms of sideroblastic anemia, this form is not responsive to <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682587.html\" target=_blank>vitamin B6</a> (pyridoxine).[4583]","dateModified":"2011-10-26T17:16:00"},"basicQuestions":[{"questionId":5556,"questionText":"What are the signs and symptoms of&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive?","answerText":"The symptoms of sideroblastic anemia are the same as for any anemia and iron overload.[1838] These may include fatigue, weakness, palpitations, shortness of breath, headaches, irritability, and chest pain.[1838][1839] Physical findings may include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003244.htm\" target=_blank>pallor</a>, <a href=\"http://www.mayoclinic.com/print/tachycardia/DS00929/DSECTION=all&amp;amp;METHOD=print\" target=_blank>tachycardia</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/17215.htm\" target=_blank>hepatosplenomegaly</a>, <a href=\"http://medical-dictionary.thefreedictionary.com/S3+gallop\" target=_blank>S3 gallop</a>, <a href=\"http://medical-dictionary.thefreedictionary.com/jugular+vein+distention\" target=_blank>jugular vein distension</a>, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003323.htm\" target=_blank>rales</a>.[1838]&nbsp;Some people with sideroblastic anemia develop diabetes or abnormal glucose tolerance which may or may not be related to the degree of iron overload. The most dangerous complication of iron overload are heart arrhythmias and heart failure, which usually occur late in the course of the disease.[4588] In severely affected children, growth and development may be affected.[4588]</span>\r\n<p></p>\r\n<p>In&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive the anemia generally remains stable over many years[4588]. However, in some individuals there is an unexplained progression of the anemia over time.[4588]</p>","dateModified":"2011-10-28T11:03:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1838,"authors":"Ferri F","articleTitle":"Anemia, Sideroblastic","bookWebsiteJournalTitle":"Ferri's Clinical Advisor 2010, 1st ed. ","date":"2009","authors2":"","placeOfPublication":"","publisher":"Elsevier"},{"referenceId":1839,"authors":"","articleTitle":"Anemias, Sideroblastic","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2007","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/anemias-sideroblastic/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":4588,"authors":"Bottomley SS, Schrier SL","articleTitle":"Clinical aspects, diagnosis, and treatment of sideroblastic anemias","bookWebsiteJournalTitle":"UpToDate","date":"2011","authors2":"Basow, DS","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":5557,"questionText":"What causes&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive?","answerText":"Sideroblastic anemia pyridoxine-refractory autosomal recessive is caused by mutations in the <em>SLC25A38</em> gene. It is inherited in an autosomal recessive fashion.[4583] <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>Click here</a> to learn more about autosomal recessive inheritance.","dateModified":"2011-10-28T10:43:00","resourceClassificationName":"Cause","references":[{"referenceId":4583,"authors":"","articleTitle":"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"2009","url":"http://omim.org/entry/205950","dateAccessed":"2011-10-26T00:00:00"}]},{"questionId":5558,"questionText":"How might&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive be treated?","answerText":"Currently there is not a cure for&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive, however with proper treatment the life-expectancy of people with&nbsp;this&nbsp;anemia&nbsp;can be close to normal. Treatments are aimed at preventing organ damage from iron overload, and controlling&nbsp;symptoms of anemia.&nbsp;People with severe anemia&nbsp;may require periodic transfusions.&nbsp;Transfusions of red cells are&nbsp;kept to a minimum, to avoid&nbsp;accelerating&nbsp;iron overload.[4588]&nbsp;Treatment of iron overload involves an iron depletion program, such as therapeutic phlebotomy or iron chelation.[4588] Total splenectomy is contraindicated in this disorder.[4588] This form of sideroblastic anemia&nbsp;is not associated with an increased risk for leukemia.[4588]<br><br>A few small studies have described the use of allogenic bone marrow or stem cell transplantation for hereditary and congenital forms of sideroblastic anemia. While these therapies may offer the possibility of a cure, the complications associated with transplantation surgery must be considered.[1840] <br><br>All patients with sideroblastic anemia should be followed by a hematologist and avoid alcohol.[1837][1838]","dateModified":"2011-10-28T10:59:00","resourceClassificationName":"Treatment","references":[{"referenceId":1837,"authors":"Escott-Stump S","articleTitle":"","bookWebsiteJournalTitle":"Nutrition and Diagnosis-Related Care","date":"2007","placeOfPublication":"","publisher":"Lippincott Williams & Wilkins"},{"referenceId":1838,"authors":"Ferri F","articleTitle":"Anemia, Sideroblastic","bookWebsiteJournalTitle":"Ferri's Clinical Advisor 2010, 1st ed. ","date":"2009","authors2":"","placeOfPublication":"","publisher":"Elsevier"},{"referenceId":1840,"authors":"Alcindor T, Bridges KR","articleTitle":"Sideroblastic Anemias","bookWebsiteJournalTitle":"The Information Center for Sickle Cell and Thalassemic Diseases","date":"2001","url":"http://sickle.bwh.harvard.edu/sideroblastic.html","dateAccessed":"2009-12-09T00:00:00"},{"referenceId":4588,"authors":"Bottomley SS, Schrier SL","articleTitle":"Clinical aspects, diagnosis, and treatment of sideroblastic anemias","bookWebsiteJournalTitle":"UpToDate","date":"2011","authors2":"Basow, DS","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":32640,"abbreviatedInquiry":"I am looking for information about this disease and also what types of treatments are available.","caseQuestions":[{"questionId":5555,"questionText":"What is sideroblastic anemia pyridoxine-refractory autosomal recessive?","answerText":"<strong>Sideroblastic anemia pyridoxine-refractory autosomal recessive </strong>is an inherited blood disorder that is&nbsp;characterized by an impaired ability of the bone marrow to produce normal red blood cells. The iron inside red blood cells is inadequately used to make <a href=\"http://sickle.bwh.harvard.edu/hemoglobin.html\" target=_blank>hemoglobin</a>, despite adequate or increased amounts of iron. Abnormal red blood cells called sideroblasts are found in the blood of people with this&nbsp;anemia.[1837] It is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene/SLC25A38\" target=_blank><em>SLC25A38</em></a> gene. It is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> fashion. Unlike other forms of sideroblastic anemia, this form is not responsive to <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682587.html\" target=_blank>vitamin B6</a> (pyridoxine).[4583]","dateModified":"2011-10-26T17:16:00","references":[{"referenceId":1837,"authors":"Escott-Stump S","articleTitle":"","bookWebsiteJournalTitle":"Nutrition and Diagnosis-Related Care","date":"2007","placeOfPublication":"","publisher":"Lippincott Williams & Wilkins"},{"referenceId":4583,"authors":"","articleTitle":"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"2009","url":"http://omim.org/entry/205950","dateAccessed":"2011-10-26T00:00:00"}]},{"questionId":5556,"questionText":"What are the signs and symptoms of&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive?","answerText":"The symptoms of sideroblastic anemia are the same as for any anemia and iron overload.[1838] These may include fatigue, weakness, palpitations, shortness of breath, headaches, irritability, and chest pain.[1838][1839] Physical findings may include <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003244.htm\" target=_blank>pallor</a>, <a href=\"http://www.mayoclinic.com/print/tachycardia/DS00929/DSECTION=all&amp;amp;METHOD=print\" target=_blank>tachycardia</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/17215.htm\" target=_blank>hepatosplenomegaly</a>, <a href=\"http://medical-dictionary.thefreedictionary.com/S3+gallop\" target=_blank>S3 gallop</a>, <a href=\"http://medical-dictionary.thefreedictionary.com/jugular+vein+distention\" target=_blank>jugular vein distension</a>, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003323.htm\" target=_blank>rales</a>.[1838]&nbsp;Some people with sideroblastic anemia develop diabetes or abnormal glucose tolerance which may or may not be related to the degree of iron overload. The most dangerous complication of iron overload are heart arrhythmias and heart failure, which usually occur late in the course of the disease.[4588] In severely affected children, growth and development may be affected.[4588]</span>\r\n<p></p>\r\n<p>In&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive the anemia generally remains stable over many years[4588]. However, in some individuals there is an unexplained progression of the anemia over time.[4588]</p>","dateModified":"2011-10-28T11:03:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1838,"authors":"Ferri F","articleTitle":"Anemia, Sideroblastic","bookWebsiteJournalTitle":"Ferri's Clinical Advisor 2010, 1st ed. ","date":"2009","authors2":"","placeOfPublication":"","publisher":"Elsevier"},{"referenceId":1839,"authors":"","articleTitle":"Anemias, Sideroblastic","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2007","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/anemias-sideroblastic/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":4588,"authors":"Bottomley SS, Schrier SL","articleTitle":"Clinical aspects, diagnosis, and treatment of sideroblastic anemias","bookWebsiteJournalTitle":"UpToDate","date":"2011","authors2":"Basow, DS","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":5557,"questionText":"What causes&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive?","answerText":"Sideroblastic anemia pyridoxine-refractory autosomal recessive is caused by mutations in the <em>SLC25A38</em> gene. It is inherited in an autosomal recessive fashion.[4583] <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>Click here</a> to learn more about autosomal recessive inheritance.","dateModified":"2011-10-28T10:43:00","resourceClassificationName":"Cause","references":[{"referenceId":4583,"authors":"","articleTitle":"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"2009","url":"http://omim.org/entry/205950","dateAccessed":"2011-10-26T00:00:00"}]},{"questionId":5558,"questionText":"How might&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive be treated?","answerText":"Currently there is not a cure for&nbsp;sideroblastic anemia pyridoxine-refractory autosomal recessive, however with proper treatment the life-expectancy of people with&nbsp;this&nbsp;anemia&nbsp;can be close to normal. Treatments are aimed at preventing organ damage from iron overload, and controlling&nbsp;symptoms of anemia.&nbsp;People with severe anemia&nbsp;may require periodic transfusions.&nbsp;Transfusions of red cells are&nbsp;kept to a minimum, to avoid&nbsp;accelerating&nbsp;iron overload.[4588]&nbsp;Treatment of iron overload involves an iron depletion program, such as therapeutic phlebotomy or iron chelation.[4588] Total splenectomy is contraindicated in this disorder.[4588] This form of sideroblastic anemia&nbsp;is not associated with an increased risk for leukemia.[4588]<br><br>A few small studies have described the use of allogenic bone marrow or stem cell transplantation for hereditary and congenital forms of sideroblastic anemia. While these therapies may offer the possibility of a cure, the complications associated with transplantation surgery must be considered.[1840] <br><br>All patients with sideroblastic anemia should be followed by a hematologist and avoid alcohol.[1837][1838]","dateModified":"2011-10-28T10:59:00","resourceClassificationName":"Treatment","references":[{"referenceId":1837,"authors":"Escott-Stump S","articleTitle":"","bookWebsiteJournalTitle":"Nutrition and Diagnosis-Related Care","date":"2007","placeOfPublication":"","publisher":"Lippincott Williams & Wilkins"},{"referenceId":1838,"authors":"Ferri F","articleTitle":"Anemia, Sideroblastic","bookWebsiteJournalTitle":"Ferri's Clinical Advisor 2010, 1st ed. ","date":"2009","authors2":"","placeOfPublication":"","publisher":"Elsevier"},{"referenceId":1840,"authors":"Alcindor T, Bridges KR","articleTitle":"Sideroblastic Anemias","bookWebsiteJournalTitle":"The Information Center for Sickle Cell and Thalassemic Diseases","date":"2001","url":"http://sickle.bwh.harvard.edu/sideroblastic.html","dateAccessed":"2009-12-09T00:00:00"},{"referenceId":4588,"authors":"Bottomley SS, Schrier SL","articleTitle":"Clinical aspects, diagnosis, and treatment of sideroblastic anemias","bookWebsiteJournalTitle":"UpToDate","date":"2011","authors2":"Basow, DS","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":10824,"phenoTypeName":"Refractory anemia with ringed sideroblasts","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1130,"phenoTypeName":"Megaloblastic erythroid hyperplasia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4879,"phenoTypeName":"Normochromic anemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15533,"phenoTypeName":"Normocytic anemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8266,"phenoTypeName":"Pallor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8699,"phenoTypeName":"Abnormal fingernail morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2740,"phenoTypeName":"Abnormal number of granulocyte precursors","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1978,"phenoTypeName":"Chronic infection","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2709,"phenoTypeName":"Dysplastic granulopoesis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15563,"phenoTypeName":"Hypochromic anemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4288,"phenoTypeName":"Hyposegmentation of neutrophil nuclei","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15531,"phenoTypeName":"Abnormal bleeding","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9970,"phenoTypeName":"Acute myeloid leukemia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9566,"phenoTypeName":"Bone marrow hypocellularity","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15548,"phenoTypeName":"Granulocytopenia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9553,"phenoTypeName":"Increased megakaryocyte count","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13075,"phenoTypeName":"Leukocytosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15514,"phenoTypeName":"Neutropenia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15515,"phenoTypeName":"Pancytopenia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15530,"phenoTypeName":"Thrombocytosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":7507,"phenoTypeName":"Decreased mean corpuscular volume","percentRanges":"-"},{"phenoTypeId":628,"phenoTypeName":"Hypochromia","percentRanges":"-"},{"phenoTypeId":10976,"phenoTypeName":"Increased serum ferritin","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Sideroblastic_anemia_pyridoxine-refractory_autosomal_recessive"}